Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-27
2006-06-27
Desai, Rita (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S279000
Reexamination Certificate
active
07067666
ABSTRACT:
Methods of forming camptothecin compounds which are effective anti-tumor compounds are disclosed. These compounds inhibit the enzyme topoisomerase I and may alkylate DNA of the associated topoisomerase I-DNA cleavable complex.
REFERENCES:
patent: 5049668 (1991-09-01), Wall et al.
patent: 5122526 (1992-06-01), Wall et al.
patent: 5122606 (1992-06-01), Wani et al.
patent: 5180722 (1993-01-01), Wall et al.
patent: 5227380 (1993-07-01), Wall et al.
patent: 5340817 (1994-08-01), Wall et al.
patent: 5614529 (1997-03-01), Wall et al.
patent: 5985888 (1999-11-01), Wall et al.
patent: 6143891 (2000-11-01), Fang et al.
patent: WO 9104260 (1991-04-01), None
Walter Loos et al Structural Identification and Biological Activity of . . . Clinical Cancer Research vol. 8 pp. 856-862 Mar. 2002.
Manikumar Govindarajan
Wall Michael A.
Wani Mansukh C.
LandOfFree
7-substituted camptothecin and camptothecin analogs and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-substituted camptothecin and camptothecin analogs and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-substituted camptothecin and camptothecin analogs and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3691025